BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 27613657)

  • 1. Surgical treatment and prognosis of gastric neuroendocrine neoplasms: a single-center experience.
    Shen C; Chen H; Chen H; Yin Y; Han L; Chen J; Tang S; Yin X; Zhou Z; Zhang B; Chen Z
    BMC Gastroenterol; 2016 Sep; 16(1):111. PubMed ID: 27613657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological Findings and Treatment Outcomes of Patients with Primary Hepatobiliary Neuroendocrine Neoplasms: A Retrospective Single-institution Analysis.
    Komiyama S; Okusaka T; Maruki Y; Ohba A; Nagashio Y; Kondo S; Hijioka S; Morizane C; Ueno H; Sukeda A; Mizui T; Takamoto T; Nara S; Ban D; Esaki M; Hiraoka N; Shimada K
    Intern Med; 2024 Apr; 63(7):891-901. PubMed ID: 37612088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between clinical characteristics and survival of gastroenteropancreatic neuroendocrine neoplasms: A single-institution analysis (1995-2012) in South China.
    Wang YH; Lin Y; Xue L; Wang JH; Chen MH; Chen J
    BMC Endocr Disord; 2012 Nov; 12():30. PubMed ID: 23194346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine neoplasms of the gallbladder: A single institute analysis of outcomes and prognostic factors.
    Nandy K; Patkar S; Yadav S; Ostwal V; Ramaswamy A; Bhargav P; Goel M
    J Surg Oncol; 2024 May; 129(6):1121-1130. PubMed ID: 38348696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalized treatment of well-differentiated gastric neuroendocrine tumors based on clinicopathological classification and grading: A multicenter retrospective study.
    Huang J; Liu H; Yang D; Xu T; Wang J; Li J
    Chin Med J (Engl); 2024 Mar; 137(6):720-728. PubMed ID: 38384175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Affecting Nonfunctioning Small Pancreatic Neuroendocrine Neoplasms and Proposed New Treatment Strategies.
    Hijioka S; Yamashige D; Esaki M; Honda G; Higuchi R; Masui T; Shimizu Y; Ohtsuka M; Kumamoto Y; Katanuma A; Gotohda N; Akita H; Unno M; Endo I; Yokoyama Y; Yamada S; Matsumoto I; Ohtsuka T; Hirano S; Yasuda H; Kawai M; Aoki T; Nakamura M; Hashimoto D; Rikiyama T; Horiguchi A; Fujii T; Mizuno S; Hanada K; Tani M; Hatori T; Ito T; Okuno M; Kagawa S; Tajima H; Ishii T; Sugimoto M; Onoe S; Takami H; Takada R; Miura T; Kurita Y; Kamei K; Mataki Y; Okazaki K; Takeyama Y; Yamaue H; Satoi S;
    Clin Gastroenterol Hepatol; 2024 Apr; ():. PubMed ID: 38615727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Clinicopathological Appraisal of Duodenal Neuroendocrine Tumors at a Racially Diverse Safety Net Hospital.
    Shaikh SD; Jacoba I; Sun N; Chung E; Kim HT; Zhao Q; Weber HC
    Am J Gastroenterol; 2024 Mar; ():. PubMed ID: 38345246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric neuroendocrine neoplasms type 1: A systematic review and meta-analysis.
    Tsolakis AV; Ragkousi A; Vujasinovic M; Kaltsas G; Daskalakis K
    World J Gastroenterol; 2019 Sep; 25(35):5376-5387. PubMed ID: 31558880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric mixed neuroendocrine non-neuroendocrine neoplasms.
    Liu L; Li Q; Liu W; Qiu Z; Wu Z; Yu D; Deng W
    Front Oncol; 2024; 14():1335760. PubMed ID: 38655135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the Treatment of Gastroenteropancreatic Neuroendocrine Carcinomas: Are we Moving Forward?
    Garcia-Carbonero R; Anton-Pascual B; Modrego A; Del Carmen Riesco-Martinez M; Lens-Pardo A; Carretero-Puche C; Rubio-Cuesta B; Soldevilla B
    Endocr Rev; 2023 Jul; 44(4):724-736. PubMed ID: 36879384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in clinicopathology and prognosis between gastroesophageal junctional and gastric non-cardiac neuroendocrine carcinomas: a retrospective comparison study of consecutive 56 cases from a single institution in China.
    Cheng Y; Zhang X; Zhou X; Xu K; Lin M; Huang Q
    Am J Cancer Res; 2022; 12(10):4737-4750. PubMed ID: 36381336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early gastric mixed neuroendocrine-non-neuroendocrine neoplasms with endoscopic findings of neuroendocrine cell carcinoma components exposed on the mucosal surface: a case report.
    Ito Y; Kimoto Y; Sawada R; Nagae S; Furuta K; Takeuchi N; Takayanagi S; Kano Y; Ishii R; Sakuno T; Ono K; Negishi R; Minato Y; Muramoto T; Ohata K
    J Med Case Rep; 2022 Nov; 16(1):416. PubMed ID: 36372896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term survival of gastric mixed neuroendocrine-non-neuroendocrine neoplasm: Two case reports.
    Woo LT; Ding YF; Mao CY; Qian J; Zhang XM; Xu N
    World J Clin Cases; 2022 Aug; 10(22):7936-7943. PubMed ID: 36158478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resection of the Primary Tumor Improves the Survival of Patients With Stage IV Gastric Neuroendocrine Carcinoma.
    Li Z; Ren H; Wang T; Zhang X; Zhao L; Sun C; Niu P; Guo C; Chen Y; Zhao D
    Front Oncol; 2022; 12():930491. PubMed ID: 35912176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival According to Primary Tumor Location, Stage, and Treatment Patterns in Locoregional Gastroenteropancreatic High-grade Neuroendocrine Carcinomas.
    Dasari A; Shen C; Devabhaktuni A; Nighot R; Sorbye H
    Oncologist; 2022 Apr; 27(4):299-306. PubMed ID: 35380711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgery in Patients with Gastro-Entero-Pancreatic Neuroendocrine Carcinomas, Neuroendocrine Tumors G3 and High Grade Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms.
    Holmager P; Langer SW; Kjaer A; Ringholm L; Garbyal RS; Pommergaard HC; Hansen CP; Federspiel B; Andreassen M; Knigge U
    Curr Treat Options Oncol; 2022 Jun; 23(6):806-817. PubMed ID: 35362798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early gastric mixed neuroendocrine-non-neuroendocrine neoplasm with early poor prognosis after endoscopic submucosal dissection: A case report.
    Tomita Y; Seki H; Matsuzono E; Kobayashi Y; Sogabe S; Sugai N; Fujita J; Suzuki A
    DEN Open; 2022 Apr; 2(1):e10. PubMed ID: 35310728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine Carcinomas of the Digestive Tract: What Is New?
    Pellat A; Cottereau AS; Terris B; Coriat R
    Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor size and perineural invasion predict outcome of gastric high-grade neuroendocrine neoplasms.
    Zhang Q; Wang H; Xie Y; Huang S; Chen K; Ye B; Yang Y; Sun J; He H; Liu F; Shen Z; Chen W; Shen K; Ji Y; Sun Y
    Endocr Connect; 2021 Aug; 10(8):947-954. PubMed ID: 34289448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological characteristics and prognosis of 232 patients with poorly differentiated gastric neuroendocrine neoplasms.
    Han D; Li YL; Zhou ZW; Yin F; Chen J; Liu F; Shi YF; Wang W; Zhang Y; Yu XJ; Xu JM; Yang RX; Tian C; Luo J; Tan HY
    World J Gastroenterol; 2021 Jun; 27(21):2895-2909. PubMed ID: 34135560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.